# Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery

> **NCT07567573** · — · COMPLETED · sponsor: **European Society of Gynaecological Oncology** · enrollment: 11383 (actual)

## Conditions studied

- D010051
- Ovarian Cancer
- Advanced-stage Ovarian Cancer
- FIGO Stages III and IV
- Quality Indicators

## Interventions

- **PROCEDURE:** Preoperative Evaluations
- **PROCEDURE:** Cytoreductive Surgery
- **PROCEDURE:** Perioperative Management
- **PROCEDURE:** Systemic Chemotherapy

## Key facts

- **NCT ID:** NCT07567573
- **Lead sponsor:** European Society of Gynaecological Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-26
- **Primary completion:** 2024-12-20
- **Final completion:** 2024-12-20
- **Target enrollment:** 11383 (ACTUAL)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07567573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07567573, "Validation of ESGO Quality Indicators in Advanced Ovarian Cancer Surgery". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT07567573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*